Atezolizumab in Kombination mit Bevacizumab und Chemotherapie versus Bevacizumab und Chemotherapie beim rezidivierendem Ovarialkarzinom – eine randomisierte Phase III Studie

A single arm phase II, open-label, multicenter trial to investigate the clinical activity and safety of avelumab in combination with cetuximab in subjects with unresectable stage III or stage IV cutaneous squamous cell carcinoma (cSCC)

A phase II trial of nivolumab in combination with ipilimumab to evaluate efficacy and safety in relapsed lung cancer and to evaluate biomarkers predictive for response to immune checkpoint inhibition

HANNA (CA20999K): Eine nationale, prospektive, NIS mit Nivolumab bei Pat. mit Plattenepithelkarzinom im Kopf-Hals-Bereich , die eine Tumorprogression während oder nach einer platinbasierten Therapie aufweisen

Multicenter Study to Evaluate the Impact of eHealth Monitoring on Overall Survival in Patients With Metastatic Non-squamous NSCLC or Extensive-stage SCLC Under First-line Treatment With Atezolizumab and Platinum-based Chemotherapy

DURvalumab in frAil and elder PaTIents with metastatic Nsclc

Avelumab added to FOLFIRI plus cetuximab followed by avelumab maintenance in patients with previously untreated RAS/BRAF wild-type metastatic colorectal cancer - the phase II FIRE-6-avelumab study

NIS zur Beobachtung von Wirkungseffekten von Atezolizumab in der alltäglichen Routine bei Patienten mit lokal fortgeschrittenem oder metastasiertem nicht kleinzelligem Lungencarcinom nach vorheriger Chemotherapie

A Phase III, Double-Blinded, Multicenter, Randomized Study Evaluating the Efficacy and Safety of Neoadjuvant Treatment With Atezolizumab or Placebo in Combination With Platinum-Based Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non−Small Cell Lung Cancer